Abstract LB365: Mechanistic and early clinical characterization of VRN101099, a selective HER2 inhibitor with receptor degradation activity
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Garvan Institute of Medical Research, UNSW Sydney, Seoul National University, Yonsei University, Severance Hospital, Seoul National University Bundang Hospital, Gangnam Severance Hospital, The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, Samsung Medical Center, Sungkyunkwan University, Seoul National University Hospital, Yonsei University Health System, Asan Medical Center, University of Ulsan
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154745902
Cites:
Cited by:
Related to: